A Study of M802 (HER2 and CD3) in HER2-Positive Advanced Solid Tumors

Clinical trial NCT04501770 · COMPLETED

Trial details

NCT number: NCT04501770
Sponsor: Wuhan YZY Biopharma Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

HER2-Positive Solid Tumors

Start date: 2018-09-27
Primary completion: 2022-05-06
Enrollment: 34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.